AbbVie is entering the obesity treatment market with a $2.3bn licensing agreement to acquire rights to a long-acting amylin ...
BridgeBio Oncology has entered into a merger agreement with Helix Acquisition Corp II to form a combined entity.
Magnet Biomedicine has entered a partnership and licence agreement with Eli Lilly for molecular glue therapeutics.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback